P R Murray - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P R Murray

Showing results (131-140 of 143) with videos related to

Pageof 15

Sort By:

Diagnostic Microbiology and Infectious Disease|August 1, 1993

In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centersH S Sader, R N Jones, J A Washington, et al.

Journal of Clinical Microbiology|July 1, 1987

Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillinH D Isenberg, R C Tilton, A L Barry, et al.

Journal of Clinical Microbiology|January 1, 1997

Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemiaJ H Jorgensen, S Mirrett, L C McDonald, et al.

Diagnostic Microbiology and Infectious Disease|August 1, 1992

Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelinesE H Gerlach, R N Jones, S D Allen, et al.

Diagnostic Microbiology and Infectious Disease|September 1, 1991

Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelinesR N Jones, E H Gerlach, F P Koontz, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991

Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.

Antimicrobial Agents and Chemotherapy|July 1, 1991

In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolatesJ A Washington, R N Jones, S D Allen, et al.

Journal of Clinical Microbiology|September 1, 1993

Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parametersA L Barry, P C Fuchs, S D Allen, et al.

Journal of Clinical Microbiology|February 1, 1991

Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetanR N Jones, E H Gerlach, F P Koontz, et al.

Journal of Clinical Microbiology|December 29, 2006

Genotypic analysis of invasive Streptococcus pneumoniae from Mali, Africa, by semiautomated repetitive-element PCR and pulsed-field gel electrophoresisS M Harrington, F Stock, A L Kominski, et al.

Pageof 15

Search research articles

Showing results (131-140 of 143) with videos related to

Sort By:

Pageof 15

Diagnostic Microbiology and Infectious Disease|August 1, 1993

In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centersH S Sader, R N Jones, J A Washington, et al.

Journal of Clinical Microbiology|July 1, 1987

Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillinH D Isenberg, R C Tilton, A L Barry, et al.

Journal of Clinical Microbiology|January 1, 1997

Diagnostic Microbiology and Infectious Disease|August 1, 1992

Diagnostic Microbiology and Infectious Disease|September 1, 1991

Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelinesR N Jones, E H Gerlach, F P Koontz, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991

Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.

Antimicrobial Agents and Chemotherapy|July 1, 1991

In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolatesJ A Washington, R N Jones, S D Allen, et al.

Journal of Clinical Microbiology|September 1, 1993

Journal of Clinical Microbiology|February 1, 1991

Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetanR N Jones, E H Gerlach, F P Koontz, et al.

Journal of Clinical Microbiology|December 29, 2006

Genotypic analysis of invasive Streptococcus pneumoniae from Mali, Africa, by semiautomated repetitive-element PCR and pulsed-field gel electrophoresisS M Harrington, F Stock, A L Kominski, et al.

Pageof 15